GEODE CAPITAL MANAGEMENT, LLC - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 86 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2024$1,498,243
+35.9%
2,158,591
+0.4%
0.00%
Q4 2023$1,102,719
-64.1%
2,150,150
+3.5%
0.00%
Q3 2023$3,073,721
-6.0%
2,076,575
+2.2%
0.00%
Q2 2023$3,270,800
-41.1%
2,031,553
+6.1%
0.00%
-100.0%
Q1 2023$5,552,276
+91718.7%
1,914,578
+3.8%
0.00%0.0%
Q4 2022$6,047
-99.9%
1,843,618
+4.1%
0.00%0.0%
Q3 2022$6,695,000
-49.8%
1,771,324
+3.5%
0.00%
-50.0%
Q2 2022$13,332,000
-14.6%
1,711,450
+1.8%
0.00%0.0%
Q1 2022$15,617,000
-38.8%
1,681,106
+3.7%
0.00%
-33.3%
Q4 2021$25,538,000
-3.1%
1,620,465
+10.0%
0.00%
-25.0%
Q3 2021$26,363,000
+12.0%
1,472,822
-2.7%
0.00%
+33.3%
Q2 2021$23,547,000
+15.5%
1,514,324
+6.7%
0.00%0.0%
Q1 2021$20,383,000
-13.8%
1,419,436
+17.8%
0.00%
-25.0%
Q4 2020$23,645,000
+71.6%
1,204,541
+13.3%
0.00%
+33.3%
Q3 2020$13,782,000
+6.9%
1,063,435
+20.2%
0.00%0.0%
Q2 2020$12,889,000
+83.0%
884,674
+6.9%
0.00%
+50.0%
Q1 2020$7,043,000
-70.8%
827,730
-43.6%
0.00%
-33.3%
Q4 2019$24,158,000
+145.7%
1,466,894
+110.6%
0.00%
+50.0%
Q3 2019$9,833,000
-18.1%
696,492
+16.7%
0.00%
-33.3%
Q2 2019$12,005,000
-44.7%
596,983
+9.4%
0.00%
-50.0%
Q1 2019$21,699,000
-37.3%
545,911
-45.2%
0.01%
+20.0%
Q4 2018$34,606,000
+85.4%
996,156
+120.6%
0.01%0.0%
Q3 2018$18,670,000
+19.4%
451,532
+6.1%
0.01%0.0%
Q2 2018$15,643,000
+14.0%
425,680
+21.0%
0.01%
+25.0%
Q1 2018$13,718,000
+285.1%
351,753
+78.7%
0.00%
+300.0%
Q4 2017$3,562,000
+12.0%
196,841
+2.5%
0.00%0.0%
Q3 2017$3,179,000
+20.6%
192,110
+2.0%
0.00%0.0%
Q2 2017$2,637,000
-26.1%
188,425
+8.5%
0.00%0.0%
Q1 2017$3,568,000
+51.1%
173,639
+4.3%
0.00%0.0%
Q4 2016$2,362,000
-24.6%
166,408
+13.6%
0.00%
-50.0%
Q3 2016$3,132,000
+1.0%
146,463
+6.3%
0.00%0.0%
Q2 2016$3,100,000
+27.4%
137,725
+7.7%
0.00%
+100.0%
Q1 2016$2,433,000
-30.3%
127,880
-3.3%
0.00%
-50.0%
Q4 2015$3,492,000
-8.1%
132,254
+9.4%
0.00%0.0%
Q3 2015$3,800,000
+11.8%
120,893
+87.6%
0.00%0.0%
Q2 2015$3,399,000
+43.5%
64,431
+13.0%
0.00%
+100.0%
Q1 2015$2,369,000
+151.8%
57,002
+62.0%
0.00%0.0%
Q4 2014$941,00035,1840.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
BRIDGER MANAGEMENT, LLC 1,752,690$69,669,0005.51%
Redmile Group, LLC 4,485,417$178,295,0005.22%
Camber Capital Management LP 2,000,000$79,500,0003.96%
UNIVERSITY OF NOTRE DAME DU LAC 274,229$10,901,0002.43%
Baupost Group 6,380,519$253,626,0002.13%
Artal Group S.A. 1,150,000$45,713,0001.87%
Cormorant Asset Management, LP 550,000$21,863,0001.48%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 175,000$6,956,0000.91%
HIGHLINE CAPITAL MANAGEMENT, L.P. 277,183$11,018,0000.69%
Birchview Capital, LP 24,000$954,0000.60%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders